Geoffrey J Lindeman (Geoffrey Lindeman, G J Lindeman)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 43

Top Topics

Endoplasmic Reticulum

Estrogen Receptor

Immune Response

Top Venues

Nature medicine

Nature communications

Nature cell biology

Growth factors (Chur, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Emma J Thompson, Samantha Escarbe, Denis Tvorogov, Gelareh Farshid, Philip A Gregory, Yeesim Khew-Goodall, Stephen Madden, Wendy V Ingman, Geoffrey J Lindeman, Elgene Lim, Angel F Lopez, Claudine S Bonder
Interleukin-3 production by basal-like breast cancer cells is associated with poor prognosis. Growth factors (Chur, Switzerland) 42 (2) (2024)
Toru Mukohara, Yeon Hee Park, David Sommerhalder, Kan Yonemori, Erika Paige Hamilton, Sung-Bae Kim, Jee Hyun Kim, Hiroji Iwata, Toshinari Yamashita, Rachel M Layman, Monica Mita, Timothy Clay, Yee Soo Chae, Catherine Oakman, Fengting Yan, Gun Min Kim, Seock-Ah Im, Geoffrey J Lindeman, Hope S Rugo, Marlon Liyanage, Michelle Saul, Christophe Le Corre, Athanasia Skoura, Li Liu, Meng Li, Patricia M LoRusso
Author Correction: Inhibition of lysine acetyltransferase KAT6 in ER + HER2 - metastatic breast cancer: a phase 1 trial. Nature medicine (2024)
Rachel Joyce, Rosa Pascual, Luuk Heitink, Bianca D Capaldo, François Vaillant, Michael Christie, Minhsuang Tsai, Elliot Surgenor, Casey J A Anttila, Pradeep Rajasekhar, Felicity C Jackling, Marie Trussart, Michael J G Milevskiy, Xiaoyu Song, Mengbo Li, Charis E Teh, Daniel H D Gray, null null, Aaron T L Lun, Yunshun Chen, Geoffrey J Lindeman, Jane E Visvader
Identification of aberrant luminal progenitors and mTORC1 as a potential breast cancer prevention target in BRCA2 mutation carriers. Nature cell biology 26 (1) (2024)
Rachel Joyce, Rosa Pascual, Luuk Heitink, Bianca D Capaldo, François Vaillant, Michael Christie, Minhsuang Tsai, Elliot Surgenor, Casey J A Anttila, Pradeep Rajasekhar, Felicity C Jackling, Marie Trussart, Michael J G Milevskiy, Xiaoyu Song, Mengbo Li, Charis E Teh, Daniel H D Gray, null null, Aaron T L Lun, Yunshun Chen, Geoffrey J Lindeman, Jane E Visvader
Identification of aberrant luminal progenitors and mTORC1 as a potential breast cancer prevention target in BRCA2 mutation carriers. Nature cell biology (2024)
Toru Mukohara, Yeon Hee Park, David Sommerhalder, Kan Yonemori, Erika Paige Hamilton, Sung-Bae Kim, Jee Hyun Kim, Hiroji Iwata, Toshinari Yamashita, Rachel M Layman, Monica Mita, Timothy Clay, Yee Soo Chae, Catherine Oakman, Fengting Yan, Gun Min Kim, Seock-Ah Im, Geoffrey J Lindeman, Hope S Rugo, Marlon Liyanage, Michelle Saul, Christophe Le Corre, Athanasia Skoura, Li Liu, Meng Li, Patricia M LoRusso
Inhibition of lysine acetyltransferase KAT6 in ER + HER2 - metastatic breast cancer: a phase 1 trial. Nature medicine 30 (8) (2024)
Toru Mukohara, Yeon Hee Park, David Sommerhalder, Kan Yonemori, Erika Paige Hamilton, Sung-Bae Kim, Jee Hyun Kim, Hiroji Iwata, Toshinari Yamashita, Rachel M Layman, Monica Mita, Timothy Clay, Yee Soo Chae, Catherine Oakman, Fengting Yan, Gun Min Kim, Seock-Ah Im, Geoffrey J Lindeman, Hope S Rugo, Marlon Liyanage, Michelle Saul, Christophe Le Corre, Athanasia Skoura, Li Liu, Meng Li, Patricia M LoRusso
Inhibition of lysine acetyltransferase KAT6 in ER + HER2 - metastatic breast cancer: a phase 1 trial. Nature medicine (2024)
Emma J Thompson, Samantha Escarbe, Denis Tvorogov, Gelareh Farshid, Philip A Gregory, Yeesim Khew-Goodall, Stephen Madden, Wendy V Ingman, Geoffrey J Lindeman, Elgene Lim, Angel F Lopez, Claudine S Bonder
Interleukin-3 production by basal-like breast cancer cells is associated with poor prognosis. Growth factors (Chur, Switzerland) (2024)
Toru Mukohara, Yeon Hee Park, David Sommerhalder, Kan Yonemori, Erika Paige Hamilton, Sung-Bae Kim, Jee Hyun Kim, Hiroji Iwata, Toshinari Yamashita, Rachel M Layman, Monica Mita, Timothy Clay, Yee Soo Chae, Catherine Oakman, Fengting Yan, Gun Min Kim, Seock-Ah Im, Geoffrey J Lindeman, Hope S Rugo, Marlon Liyanage, Michelle Saul, Christophe Le Corre, Athanasia Skoura, Li Liu, Meng Li, Patricia M LoRusso
Author Correction: Inhibition of lysine acetyltransferase KAT6 in ER + HER2 - metastatic breast cancer: a phase 1 trial. Nature medicine (2024)
Toru Mukohara, Yeon Hee Park, David Sommerhalder, Kan Yonemori, Erika Paige Hamilton, Sung-Bae Kim, Jee Hyun Kim, Hiroji Iwata, Toshinari Yamashita, Rachel M Layman, Monica Mita, Timothy Clay, Yee Soo Chae, Catherine Oakman, Fengting Yan, Gun Min Kim, Seock-Ah Im, Geoffrey J Lindeman, Hope S Rugo, Marlon Liyanage, Michelle Saul, Christophe Le Corre, Athanasia Skoura, Li Liu, Meng Li, Patricia M LoRusso
Inhibition of lysine acetyltransferase KAT6 in ER + HER2 - metastatic breast cancer: a phase 1 trial. Nature medicine (2024)
Emma J Thompson, Samantha Escarbe, Denis Tvorogov, Gelareh Farshid, Philip A Gregory, Yeesim Khew-Goodall, Stephen Madden, Wendy V Ingman, Geoffrey J Lindeman, Elgene Lim, Angel F Lopez, Claudine S Bonder
Interleukin-3 production by basal-like breast cancer cells is associated with poor prognosis. Growth factors (Chur, Switzerland) 42 (2) (2024)
Rachel Joyce, Rosa Pascual, Luuk Heitink, Bianca D Capaldo, François Vaillant, Michael Christie, Minhsuang Tsai, Elliot Surgenor, Casey J A Anttila, Pradeep Rajasekhar, Felicity C Jackling, Marie Trussart, Michael J G Milevskiy, Xiaoyu Song, Mengbo Li, Charis E Teh, Daniel H D Gray, null null, Aaron T L Lun, Yunshun Chen, Geoffrey J Lindeman, Jane E Visvader
Identification of aberrant luminal progenitors and mTORC1 as a potential breast cancer prevention target in BRCA2 mutation carriers. Nature cell biology 26 (1) (2024)
Toru Mukohara, Yeon Hee Park, David Sommerhalder, Kan Yonemori, Erika Paige Hamilton, Sung-Bae Kim, Jee Hyun Kim, Hiroji Iwata, Toshinari Yamashita, Rachel M Layman, Monica Mita, Timothy Clay, Yee Soo Chae, Catherine Oakman, Fengting Yan, Gun Min Kim, Seock-Ah Im, Geoffrey J Lindeman, Hope S Rugo, Marlon Liyanage, Michelle Saul, Christophe Le Corre, Athanasia Skoura, Li Liu, Meng Li, Patricia M LoRusso
Inhibition of lysine acetyltransferase KAT6 in ER + HER2 - metastatic breast cancer: a phase 1 trial. Nature medicine 30 (8) (2024)
Rachel Joyce, Rosa Pascual, Luuk Heitink, Bianca D Capaldo, François Vaillant, Michael Christie, Minhsuang Tsai, Elliot Surgenor, Casey J A Anttila, Pradeep Rajasekhar, Felicity C Jackling, Marie Trussart, Michael J G Milevskiy, Xiaoyu Song, Mengbo Li, Charis E Teh, Daniel H D Gray, null null, Aaron T L Lun, Yunshun Chen, Geoffrey J Lindeman, Jane E Visvader
Identification of aberrant luminal progenitors and mTORC1 as a potential breast cancer prevention target in BRCA2 mutation carriers. Nature cell biology 26 (1) (2024)
Toru Mukohara, Yeon Hee Park, David Sommerhalder, Kan Yonemori, Erika Paige Hamilton, Sung-Bae Kim, Jee Hyun Kim, Hiroji Iwata, Toshinari Yamashita, Rachel M Layman, Monica Mita, Timothy Clay, Yee Soo Chae, Catherine Oakman, Fengting Yan, Gun Min Kim, Seock-Ah Im, Geoffrey J Lindeman, Hope S Rugo, Marlon Liyanage, Michelle Saul, Christophe Le Corre, Athanasia Skoura, Li Liu, Meng Li, Patricia M LoRusso
Inhibition of lysine acetyltransferase KAT6 in ER + HER2 - metastatic breast cancer: a phase 1 trial. Nature medicine 30 (8) (2024)
Emma J Thompson, Samantha Escarbe, Denis Tvorogov, Gelareh Farshid, Philip A Gregory, Yeesim Khew-Goodall, Stephen Madden, Wendy V Ingman, Geoffrey J Lindeman, Elgene Lim, Angel F Lopez, Claudine S Bonder
Interleukin-3 production by basal-like breast cancer cells is associated with poor prognosis. Growth factors (Chur, Switzerland) 42 (2) (2024)
Toru Mukohara, Yeon Hee Park, David Sommerhalder, Kan Yonemori, Erika Paige Hamilton, Sung-Bae Kim, Jee Hyun Kim, Hiroji Iwata, Toshinari Yamashita, Rachel M Layman, Monica Mita, Timothy Clay, Yee Soo Chae, Catherine Oakman, Fengting Yan, Gun Min Kim, Seock-Ah Im, Geoffrey J Lindeman, Hope S Rugo, Marlon Liyanage, Michelle Saul, Christophe Le Corre, Athanasia Skoura, Li Liu, Meng Li, Patricia M LoRusso
Inhibition of lysine acetyltransferase KAT6 in ER + HER2 - metastatic breast cancer: a phase 1 trial. Nature medicine (2024)
Taru A Muranen, Anna Morra, Sofia Khan, Daniel R Barnes, Manjeet K Bolla, Joe G Dennis, Renske Keeman, Goska Leslie, Michael T Parsons, Qin Wang, Thomas U Ahearn, Kristiina Aittomäki, Irene L Andrulis, Banu K Arun, Sabine Behrens, Katarzyna Bialkowska, Stig E Bojesen, Nicola J Camp, Jenny Chang-Claude, Kamila Czene, Peter Devilee, null null, Susan M Domchek, Alison M Dunning, Christoph Engel, Dafydd Gareth Evans, Manuela Gago-Dominguez, Montserrat Garcia-Closas, Anne-Marie Gerdes, Gord Glendon, Pascal Guénel, Eric Hahnen, Ute Hamann, Helen Hanson, Maartje J Hooning, Reiner Hoppe, Louise Izatt, Anna Jakubowska, Paul A James, Vessela N Kristensen, Fiona Lalloo, Geoffrey J Lindeman, Arto Mannermaa, Sara Margolin, Susan L Neuhausen, William G Newman, Paolo Peterlongo, Kelly-Anne Phillips, Miquel Angel Pujana, Johanna Rantala, Karina Rønlund, Emmanouil Saloustros, Rita K Schmutzler, Andreas Schneeweiss, Christian F Singer, Maija Suvanto, Yen Yen Tan, Manuel R Teixeira, Mads Thomassen, Marc Tischkowitz, Vishakha Tripathi, Barbara Wappenschmidt, Emily Zhao, Douglas F Easton, Antonis C Antoniou, Georgia Chenevix-Trench, Paul David Peter Pharoah, Marjanka K Schmidt, Carl Blomqvist, Heli Nevanlinna
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants. NPJ breast cancer 9 (1) (2023)
Taru A Muranen, Anna Morra, Sofia Khan, Daniel R Barnes, Manjeet K Bolla, Joe G Dennis, Renske Keeman, Goska Leslie, Michael T Parsons, Qin Wang, Thomas U Ahearn, Kristiina Aittomäki, Irene L Andrulis, Banu K Arun, Sabine Behrens, Katarzyna Bialkowska, Stig E Bojesen, Nicola J Camp, Jenny Chang-Claude, Kamila Czene, Peter Devilee, null null, Susan M Domchek, Alison M Dunning, Christoph Engel, Dafydd Gareth Evans, Manuela Gago-Dominguez, Montserrat Garcia-Closas, Anne-Marie Gerdes, Gord Glendon, Pascal Guénel, Eric Hahnen, Ute Hamann, Helen Hanson, Maartje J Hooning, Reiner Hoppe, Louise Izatt, Anna Jakubowska, Paul A James, Vessela N Kristensen, Fiona Lalloo, Geoffrey J Lindeman, Arto Mannermaa, Sara Margolin, Susan L Neuhausen, William G Newman, Paolo Peterlongo, Kelly-Anne Phillips, Miquel Angel Pujana, Johanna Rantala, Karina Rønlund, Emmanouil Saloustros, Rita K Schmutzler, Andreas Schneeweiss, Christian F Singer, Maija Suvanto, Yen Yen Tan, Manuel R Teixeira, Mads Thomassen, Marc Tischkowitz, Vishakha Tripathi, Barbara Wappenschmidt, Emily Zhao, Douglas F Easton, Antonis C Antoniou, Georgia Chenevix-Trench, Paul David Peter Pharoah, Marjanka K Schmidt, Carl Blomqvist, Heli Nevanlinna
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants. NPJ breast cancer 9 (1) (2023)
Dilanka L De Silva, Lesley Stafford, Anita R Skandarajah, Michelle Sinclair, Lisa Devereux, Kirsten Hogg, Maira Kentwell, Allan Park, Luxi Lal, Magnus Zethoven, Madawa W Jayawardana, Fiona Chan, Phyllis N Butow, Paul A James, G Bruce Mann, Ian G Campbell, Geoffrey J Lindeman
Universal genetic testing for women with newly diagnosed breast cancer in the context of multidisciplinary team care. The Medical journal of Australia (2023)
Zhi Ling Teo, Lenka Oplustil O'Connor, Stephanie Versaci, Kylie A Clarke, Emmaline R Brown, Luke W Percy, Keilly Kuykhoven, Christopher P Mintoff, Peter Savas, Balaji Virassamy, Stephen J Luen, Ann Byrne, Sneha Sant, Geoffrey J Lindeman, Phillip K Darcy, Sherene Loi
Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer. NPJ breast cancer 9 (1) (2023)
Christine Muttiah, James R Whittle, Catherine Oakman, Geoffrey J Lindeman
PALVEN: phase Ib trial of palbociclib, letrozole and venetoclax in estrogen receptor- and BCL2-positive advanced breast cancer. Future oncology (London, England) 18 (15) (2022)
Geoffrey J Lindeman, Tharu M Fernando, Rebecca Bowen, Katarzyna J Jerzak, Xinni Song, Thomas Decker, Frances Boyle, Steven McCune, Anne C Armstrong, Catherine Shannon, Gianfilippo Bertelli, Ching-Wei Chang, Rupal Desai, Kushagra Gupta, Timothy R Wilson, Aulde Flechais, Aditya Bardia
VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors - Efficacy, Safety, and Biomarker Results. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (15) (2022)
Yunshun Chen, Bhupinder Pal, Geoffrey J Lindeman, Jane E Visvader, Aaron T L Lun
R code and downstream analysis objects for the scRNA-seq atlas of normal and tumorigenic human breast tissue. Scientific data 9 (1) (2022)
Charis E Teh, Hongke Peng, Meng-Xiao Luo, Tania Tan, Marie Trussart, Lauren J Howson, Chong Chyn Chua, Christine Muttiah, Fiona C Brown, Matthew E Ritchie, Andrew H Wei, Andrew W Roberts, Vanessa L Bryant, Mary Ann Anderson, Geoffrey J Lindeman, David Ching Siang Huang, Rachel Thijssen, Daniel H D Gray
Venetoclax treatment in cancer patients has limited impact on circulating T and NK cells. Blood advances (2022)
Luuk Heitink, James R Whittle, François Vaillant, Bianca D Capaldo, Johanna F Dekkers, Caleb A Dawson, Michael J G Milevskiy, Elliot Surgenor, Minhsuang Tsai, Huei-Rong Chen, Michael Christie, Yunshun Chen, Aaron T L Lun, Marco J Herold, Andreas Strasser, Geoffrey J Lindeman, Jane E Visvader
In vivo genome-editing screen identifies tumor suppressor genes that cooperate with Trp53 loss during mammary tumorigenesis. Molecular oncology 16 (5) (2022)
Bhupinder Pal, Yunshun Chen, François Vaillant, Bianca D Capaldo, Rachel Joyce, Xiaoyu Song, Vanessa L Bryant, Jocelyn S Penington, Leon Di Stefano, Nina Tubau Ribera, Stephen Wilcox, Gregory B Mann, null null, Anthony T Papenfuss, Geoffrey J Lindeman, Aaron T L Lun, Jane E Visvader
A single-cell RNA expression atlas of normal, preneoplastic and tumorigenic states in the human breast. The EMBO journal 40 (11) (2021)
Dilanka L De Silva, Paul A James, G Bruce Mann, Geoffrey J Lindeman
Universal genetic testing of patients with newly diagnosed breast cancer - ready for prime time? The Medical journal of Australia 215 (10) (2021)
Christoph Grohmann, Francesca Walker, Mark Devlin, Meng-Xiao Luo, Anderly C Chüeh, Judy Doherty, François Vaillant, Gwo-Yaw Ho, Matthew J Wakefield, Clare E Weeden, Alvin Kamili, Jayne Murray, Sela T Po'uha, Janet Weinstock, Serena R Kane, Maree C Faux, Esmee Broekhuizen, Ye Zheng, Kristy Shield-Artin, Nadia J Kershaw, Chin Wee Tan, Helen M Witchard, Gregor Ebert, Susan A Charman, Ian Street, Maria Kavallaris, Michelle Haber, Jamie I Fletcher, Marie-Liesse Asselin-Labat, Clare L Scott, Jane E Visvader, Geoffrey J Lindeman, Keith G Watson, Antony W Burgess, Guillaume L Lessene
Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumors. Cell death & disease 12 (3) (2021)
Raymond K H Yip, Joel S Rimes, Bianca D Capaldo, François Vaillant, Kellie A Mouchemore, Bhupinder Pal, Yunshun Chen, Elliot Surgenor, Andrew J Murphy, Robin L Anderson, Aaron T L Lun, Geoffrey J Lindeman, Edwin D Hawkins, Jane E Visvader
Mammary tumour cells remodel the bone marrow vascular microenvironment to support metastasis. Nature communications 12 (1) (2021)
Clara Gómez-Aleza, Bastien Nguyen, Guillermo Yoldi, Marina Ciscar, Alexandra Barranco, Enrique Hernández-Jiménez, Marion Maetens, Roberto Salgado, Maria Zafeiroglou, Pasquale Pellegrini, David Venet, Soizic Garaud, Eva María Trinidad, Sandra Benítez, Peter Vuylsteke, Laura Polastro, Hans P M W Wildiers, Philippe Simon, Geoffrey J Lindeman, Denis Larsimont, Gert Van den Eynden, Chloé Velghe, Françoise Rothé, Karen Willard-Gallo, Stefan Michiels, Purificación Muñoz, Thierry Walzer, Lourdes Planelles, Josef Penninger, Hatem A Azim, Sherene Loi, Martine Piccart, Christos Sotiriou, Eva Gonzalez Suarez
Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells. Nature communications 11 (1) (2020)
James R Whittle, François Vaillant, Elliot Surgenor, Antonia N Policheni, Göknur Giner, Bianca D Capaldo, Huei-Rong Chen, He K Liu, Johanna F Dekkers, Norman Sachs, Hans Clevers, Andrew Fellowes, Thomas Green, Huiling Xu, Stephen B Fox, Marco J Herold, Aaron T L Lun, Daniel H D Gray, Jane E Visvader, Geoffrey J Lindeman
Dual Targeting of CDK4/6 and BCL2 Pathways Augments Tumor Response in Estrogen Receptor-Positive Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (15) (2020)
Najoua Lalaoui, Delphine Merino, Goknur Giner, François Vaillant, Diep Chau, Lin Liu, Tobias Kratina, Bhupinder Pal, James R Whittle, Nima Etemadi, Jean Berthelet, Julius Gräsel, Cathrine Hall, Matthew E Ritchie, Matthias Ernst, Aaron T L Lun, David L Vaux, Jane E Visvader, Geoffrey J Lindeman, John Silke
Targeting triple-negative breast cancers with the Smac-mimetic birinapant. Cell death and differentiation 27 (10) (2020)
Caleb A Dawson, Bhupinder Pal, François Vaillant, Luke C Gandolfo, Zhaoyuan Liu, Camille Bleriot, Florent Ginhoux, Aaron T L Lun, Geoffrey J Lindeman, Scott N Mueller, Anne C Rios, Jane E Visvader
Tissue-resident ductal macrophages survey the mammary epithelium and facilitate tissue remodelling. Nature cell biology 22 (5) (2020)
Stefano Annunziato, Julian R de Ruiter, Linda Henneman, Chiara S Brambillasca, Catrin Lutz, François Vaillant, Federica Ferrante, Anne Paulien Drenth, Eline van der Burg, Bjørn Siteur, Bas van Gerwen, Roebi de Bruijn, Martine H van Miltenburg, Ivo J Huijbers, Marieke van de Ven, Jane E Visvader, Geoffrey J Lindeman, Lodewyk F A Wessels, Jos Jonkers
Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer. Nature communications 10 (1) (2019)
Véronique Diéras, Hervé Bonnefoi, Emilio Alba, Ahmad Awada, Bruno Coudert, Xavier Pivot, Joseph Gligorov, Agnes Jager, Stefania Zambelli, Geoffrey J Lindeman, Eric Charpentier, Gary T Emmons, Ignacio Garcia-Ribas, Robert Paridaens, Jaap Verweij
Iniparib administered weekly or twice-weekly in combination with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: a phase II randomized open-label study with pharmacokinetics. Breast cancer research and treatment 177 (2) (2019)
Delphine Merino, Tom S Weber, A Serrano, François Vaillant, K Liu, Bhupinder Pal, Leon Di Stefano, Jaring Schreuder, Dawn S Lin, Yunshun Chen, Marie-Liesse Asselin-Labat, Ton N M Schumacher, Daniel L Cameron, Aaron T L Lun, Anthony T Papenfuss, Geoffrey J Lindeman, Jane E Visvader, Shalin H Naik
Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer. Nature communications 10 (1) (2019)
Delphine Merino, Tom S Weber, A Serrano, François Vaillant, K Liu, Bhupinder Pal, Leon Di Stefano, Jaring Schreuder, Dawn S Lin, Yunshun Chen, Marie-Liesse Asselin-Labat, Ton N M Schumacher, Daniel L Cameron, Aaron T L Lun, Anthony T Papenfuss, Geoffrey J Lindeman, Jane E Visvader, Shalin H Naik
Publisher Correction: Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer. Nature communications 10 (1) (2019)
Emma Nolan, Peter Savas, Antonia N Policheni, Phillip K Darcy, François Vaillant, Christopher P Mintoff, Sathana Dushyanthen, Mariam Mansour, Jia-Min B Pang, Stephen B Fox, null null, Charles M Perou, Jane E Visvader, Daniel H D Gray, Sherene Loi, Geoffrey J Lindeman
Combined immune checkpoint blockade as a therapeutic strategy for BRCA1-mutated breast cancer. Science translational medicine 9 (393) (2018)
Sheau W Lok, James R Whittle, François Vaillant, Charis E Teh, Louisa L Lo, Antonia N Policheni, Alice R T Bergin, Jayesh Desai, Sarah Ftouni, Luke C Gandolfo, Danny Liew, He K Liu, G Bruce Mann, Kate Moodie, Anand Murugasu, Bhupinder Pal, Andrew W Roberts, Mark A Rosenthal, Kylie Shackleton, Maria João Silva, Zhen R Siow, Aaron T L Lun, Leanne Taylor, Avraham Travers, Belinda Yeo, Miriam M Yeung, Andjelija Zivanovic Bujak, Sarah-Jane Dawson, Daniel H D Gray, Jane E Visvader, Geoffrey J Lindeman
A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast Cancer. Cancer discovery 9 (3) (2018)
Nai Yang Fu, Anne C Rios, Bhupinder Pal, Charity W Law, Paul Jamieson, Ruijie Liu, François Vaillant, Felicity Jackling, Kevin He Liu, Aaron T L Lun, Geoffrey J Lindeman, Matthew E Ritchie, Jane E Visvader
Identification of quiescent and spatially restricted mammary stem cells that are hormone responsive. Nature cell biology 19 (3) (2017)
Bhupinder Pal, Yunshun Chen, François Vaillant, Paul Jamieson, Lavinia Gordon, Anne C Rios, Stephen Wilcox, Naiyang Fu, Kevin He Liu, Felicity C Jackling, Melissa J Davis, Geoffrey J Lindeman, Aaron T L Lun, Jane E Visvader
Construction of developmental lineage relationships in the mouse mammary gland by single-cell RNA profiling. Nature communications 8 (1) (2017)
Anne C Rios, Nai Yang Fu, Paul R Jamieson, Bhupinder Pal, Lachlan W Whitehead, Kevin R Nicholas, Geoffrey J Lindeman, Jane E Visvader
Essential role for a novel population of binucleated mammary epithelial cells in lactation. Nature communications 7 (2016)
Emma Nolan, François Vaillant, Daniel Branstetter, Bhupinder Pal, Göknur Giner, Lachlan W Whitehead, Sheau W Lok, Gregory B Mann, null null, Kathy Rohrbach, Li-Ya Huang, Rosalia Soriano, Aaron T L Lun, William C Dougall, Jane E Visvader, Geoffrey J Lindeman
RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. Nature medicine 22 (8) (2016)